BrightSpring Health Services Inc has a consensus price target of $29.78 based on the ratings of 17 analysts. The high is $45 issued by Keybanc on December 12, 2025. The low is $11.5 issued by Deutsche Bank on February 20, 2024. The 3 most-recent analyst ratings were released by Keybanc, Stephens & Co., and B of A Securities on December 12, 2025, December 11, 2025, and December 9, 2025, respectively. With an average price target of $43.33 between Keybanc, Stephens & Co., and B of A Securities, there's an implied 19.01% upside for BrightSpring Health Services Inc from these most-recent analyst ratings.
1calculated from analyst ratings
| Get Alert | |||||
|---|---|---|---|---|---|
| Dec 12, 2025 | 23.59% | 45 | Previous Sector Weight Current Overweight | Get Alert | |
| Dec 11, 2025 | 20.85% | 44 | Previous Initiates Current Overweight | Get Alert | |
| Dec 9, 2025 | 12.61% | 3841 | Previous Buy Current Buy | Get Alert | |
| Dec 8, 2025 | — | — | Previous Initiates Current Outperform | Get Alert | |
| Nov 13, 2025 | 9.86% | 40 | Previous Initiates Current Outperform | Get Alert | |
| Nov 12, 2025 | 7.11% | 3339 | Previous Overweight Current Overweight | Get Alert | |
| Oct 29, 2025 | 12.61% | 3041 | Previous Buy Current Buy | Get Alert | |
| Oct 29, 2025 | 15.35% | 3542 | Previous Buy Current Buy | Get Alert | |
| Oct 17, 2025 | -12.11% | 2632 | Previous Outperform Current Outperform | Get Alert | |
| Oct 14, 2025 | -12.11% | 2532 | Previous Overweight Current Overweight | Get Alert | |
| Oct 13, 2025 | -3.87% | 3135 | Previous Buy Current Buy | Get Alert | |
| Oct 7, 2025 | -9.37% | 2733 | Previous Overweight Current Overweight | Get Alert | |
| Sep 10, 2025 | -14.86% | 27.531 | Previous Buy Current Buy | Get Alert | |
| May 13, 2025 | -25.84% | 2527 | Previous Overweight Current Overweight | Get Alert | |
| May 9, 2025 | -31.34% | 2025 | Previous Overweight Current Overweight | Get Alert | |
| Feb 14, 2025 | -31.34% | 2125 | Previous Overweight Current Overweight | Get Alert | |
| Jan 29, 2025 | -17.61% | 2230 | Previous Buy Current Buy | Get Alert | |
| Dec 17, 2024 | -45.07% | 1920 | Previous Overweight Current Overweight | Get Alert | |
| Dec 12, 2024 | -25.84% | 27 | Previous Initiates Current Market Outperform | Get Alert | |
| Dec 11, 2024 | -42.32% | 1921 | Previous Buy Current Buy | Get Alert | |
| Nov 27, 2024 | -42.32% | 1721 | Previous Overweight Current Overweight | Get Alert | |
| Nov 4, 2024 | -39.58% | 2022 | Previous Buy Current Buy | Get Alert | |
| Nov 4, 2024 | -45.07% | 1720 | Previous Outperform Current Outperform | Get Alert | |
| Oct 30, 2024 | -45.07% | 1620 | Previous Buy Current Buy | Get Alert | |
| Oct 11, 2024 | — | — | Previous Initiates Current Sector Weight | Get Alert | |
| Oct 3, 2024 | -45.07% | 1520 | Previous Buy Current Buy | Get Alert | |
| Oct 1, 2024 | -50.56% | — | 1518 | Previous Buy Current Buy | Get Alert |
| Aug 9, 2024 | -50.56% | 1821 | Previous Buy Current Buy | Get Alert | |
| Jun 21, 2024 | -58.8% | 15 | Previous Initiates Current Buy | Get Alert | |
| May 6, 2024 | -56.06% | 1516 | Previous Overweight Current Overweight | Get Alert | |
| Mar 6, 2024 | -64.3% | 13 | Previous Initiates Current Buy | Get Alert | |
| Mar 4, 2024 | -36.83% | 2326 | Previous Buy Current Buy | Get Alert | |
| Feb 20, 2024 | -68.42% | 11.5 | Previous Initiates Current Hold | Get Alert | |
| Feb 20, 2024 | -58.8% | 15 | Previous Initiates Current Outperform | Get Alert | |
| Feb 20, 2024 | -61.55% | 14 | Previous Initiates Current Buy | Get Alert | |
| Feb 20, 2024 | -58.8% | 15 | Previous Initiates Current Buy | Get Alert | |
| Feb 20, 2024 | -58.8% | 15 | Previous Initiates Current Overweight | Get Alert | |
| Feb 20, 2024 | -50.56% | 18 | Previous Initiates Current Buy | Get Alert | |
| Feb 20, 2024 | -50.56% | 18 | Previous Initiates Current Overweight | Get Alert | |
| Feb 20, 2024 | -28.59% | 26 | Previous Initiates Current Buy | Get Alert |
The latest price target for BrightSpring Health (NASDAQ:BTSG) was reported by Keybanc on December 12, 2025. The analyst firm set a price target for $45.00 expecting BTSG to rise to within 12 months (a possible 23.59% upside). 17 analyst firms have reported ratings in the last year.
The latest analyst rating for BrightSpring Health (NASDAQ:BTSG) was provided by Keybanc, and BrightSpring Health upgraded their overweight rating.
The last upgrade for BrightSpring Health Services Inc happened on December 12, 2025 when Keybanc raised their price target to $45. Keybanc previously had a sector weight for BrightSpring Health Services Inc.
There is no last downgrade for BrightSpring Health.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrightSpring Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrightSpring Health was filed on December 12, 2025 so you should expect the next rating to be made available sometime around December 12, 2026.
While ratings are subjective and will change, the latest BrightSpring Health (BTSG) rating was a upgraded with a price target of $0.00 to $45.00. The current price BrightSpring Health (BTSG) is trading at is $36.41, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.